Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii

被引:111
作者
Chusri, Sarunyou [1 ,2 ,3 ]
Chongsuvivatwong, Virasakdi [3 ]
Rivera, Jesabel I. [2 ]
Silpapojakul, Kachornsakdi [1 ]
Singkhamanan, Kamonnut [4 ]
McNeil, Edward [3 ]
Doi, Yohei [2 ]
机构
[1] Prince Songkla Univ, Fac Med, Div Infect Dis, Hat Yai, Thailand
[2] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA
[3] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand
[4] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Thailand
基金
美国国家卫生研究院;
关键词
ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BAUMANNII; IDENTIFICATION; BACTEREMIA; EPIDEMIOLOGY; EMERGENCE; TESTS; SPP; GENE;
D O I
10.1128/AAC.02992-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of Acinetobacter nosocomialis and Acinetobacter pittii, which belong to the A. calcoaceticus-A. baumannii complex, in hospital-acquired infections is increasingly recognized. Here we describe a retrospective cohort study of hospital-acquired A. calcoaceticus-A. baumannii complex infections at a university hospital in Thailand. A total of 222 unique cases were identified between January 2010 and December 2011. The genomospecies of the A. calcoaceticus-A. baumannii complex isolates were classified as follows: A. baumannii, 197 (89%); A. nosocomialis, 18 (8%); and A. pittii, 7 (3%). All A. nosocomialis and A. pittii isolates were susceptible to imipenem and meropenem. The patients infected with A. nosocomialis and A. pittii had lower 30-day mortality than those infected with carbapenem-susceptible A. baumannii (P = 0.025) and carbapenem-resistant A. baumannii (P = 0.013). The factors influencing 30-day mortality were infection with non-baumannii A. calcoaceticus-A. baumannii complex (hazard ratio [HR], 0.12; 95% confidence interval [CI], 0.03 to 0.51; P = 0.004), infection with carbapenem-resistant A. baumannii (HR, 1.57; 95% CI, 0.89 to 2.79; P = 0.105), appropriate empirical antimicrobial therapy (HR, 0.38; 95% CI, 0.23 to 0.61; P < 0.001), and higher acute physiology and chronic health evaluation II (APACHE II) score (HR, 1.15; 95% CI, 1.10 to 1.19; P < 0.001). In Galleria mellonella assays, the survival rates were significantly higher for the larvae infected with A. nosocomialis or A. pittii than for those infected with either carbapenem-susceptible A. baumannii or carbapenem-resistant A. baumannii, but no differences in survival rates were observed between carbapenem-susceptible A. baumannii and carbapenem-resistant A. baumannii. These findings suggest intrinsic differences in virulence between non-baumannii A. calcoaceticus-A. baumannii complex species and A. baumannii but not between carbapenem-susceptible and resistant A. baumannii.
引用
收藏
页码:4172 / 4179
页数:8
相关论文
共 26 条
[1]  
[Anonymous], 2013, PERF STAND ANT SUSC
[2]   CRITERIA FOR DISK SUSCEPTIBILITY TESTS AND QUALITY-CONTROL GUIDELINES FOR THE CEFOPERAZONE-SULBACTAM COMBINATION [J].
BARRY, AL ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (01) :13-17
[3]   Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia [J].
Chuang, Yu-Chung ;
Sheng, Wang-Huei ;
Li, Shu-Ying ;
Lin, Yu-Chi ;
Wang, Jann-Tay ;
Chen, Yee-Chun ;
Chang, Shan-Chwen .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) :352-360
[4]  
Espinal P, 2011, FUTURE MICROBIOL, V6, P495, DOI [10.2217/FMB.11.30, 10.2217/fmb.11.30]
[5]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[6]   RELIABILITY OF PHENOTYPIC TESTS FOR IDENTIFICATION OF ACINETOBACTER SPECIES [J].
GERNERSMIDT, P ;
TJERNBERG, I ;
URSING, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) :277-282
[7]   Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia [J].
Huang, Shih-Tse ;
Chiang, Mei-Chun ;
Kuo, Shu-Chen ;
Lee, Yi-Tzu ;
Chiang, Tong-Hong ;
Yang, Su-Pen ;
Ti-Yin ;
Chen, Te-Li ;
Fung, Chang-Phone .
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2012, 45 (05) :356-362
[8]   Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway [J].
Karah, Nabil ;
Haldorsen, Bjorg ;
Hegstad, Kristin ;
Simonsen, Gunnar Skov ;
Sundsfjord, Arnfinn ;
Samuelsen, Orjan .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) :738-744
[9]   Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species [J].
La Scola, B ;
Gundi, VAKB ;
Khamis, A ;
Raoult, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (03) :827-832
[10]   Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes [J].
Lee, Yi-Chieh ;
Huang, Yu-Tsung ;
Tan, Che-Kim ;
Kuo, Yao-Wen ;
Liao, Chun-Hsing ;
Lee, Ping-Ing ;
Hsueh, Po-Ren .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (08) :1839-1846